News

Sarepta (SRPT) plans to continue Elevidys shipments for Duchenne muscular dystrophy, despite FDA request not to do so after ...
Analysts are intrested in these 5 stocks: ( ($JPM) ), ( ($SBUX) ), ( ($HPE) ), ( ($SRPT) ) and ( ($ELV) ). Here is a breakdown of their recent ...
Sarepta rebuffed a call from the Food and Drug Administration to halt all shipments of its gene therapy for Duchenne muscular ...
One of biotech’s highest fliers, Sarepta Therapeutics, lost more than a third of its market value on Friday after executives said that one of its experimental gene-replacement therapies was linked to ...
Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.
Why didn’t federal prosecutors charge Sean Combs with more obvious, easy-to-prove offenses? Because they can’t help themselves?
The Milwaukee Bucks got everyone's attention with their outside-the-box maneuvers July 1, but national writers aren't sure they'll work.
Ukraine received mixed results during the 2025 NATO summit. Given this ambiguity, time will tell how the NATO-Ukraine relationship will unfold.
Review quarterly and annual revenue, net income, and cash flow for Sarepta Therapeutics Inc (SRPT:XMEX) stock through the last fiscal year.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on June 30, 2025 that were previously approved by the Compensation ...
Recent discussions on X about AST SpaceMobile (ASTS) have been buzzing with activity, largely driven by the company's latest financial maneuvers and analyst coverage. Many users have pointed out ...